Repurposing Gaucher disease therapy for Saposin C deficiency: Proof-of-concept with eliglustat.
Minea C, Deegan PB.
europepmc +1 more source
Establishment of an N-Glycan Profiling Method for Three ERT Enzymes Used in Gaucher Disease Therapy. [PDF]
Chen J +6 more
europepmc +1 more source
Addressing kyphoscoliosis in Gaucher's disease: a multidisciplinary approach to a rare case. [PDF]
Guo J +5 more
europepmc +1 more source
Multidrug resistance and myelomonocytic leukaemia in gaucher's disease
Ganeshaguru, K +4 more
core
Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes. [PDF]
Kilavuz S +16 more
europepmc +1 more source
Transcriptomic Profiling of Monozygotic Twins with Type 1 Gaucher Disease. [PDF]
İnci A +8 more
europepmc +1 more source
Real-World Effectiveness and Safety of Eliglustat in Adult Patients with Gaucher Disease Type 1: A Multicenter Retrospective Study in China. [PDF]
Zhou Y, Hao Z, Zhuang Q, Han B.
europepmc +1 more source
The Gaucher Earlier Diagnosis Consensus point-scoring system for children and young adults: a retrospective and prospective evaluation in Korea. [PDF]
Hahn SM +16 more
europepmc +1 more source
Genomic Structural Equation Modeling Provides an Initial View of the Genetic Architecture Related to Type 1 Gaucher Disease. [PDF]
Ren S, Du M, Liu J, Li B, Liu J, Lang X.
europepmc +1 more source
Case Report: Progressive myoclonus epilepsy as an early manifestation of neuronopathic Gaucher disease. [PDF]
Fang Z +5 more
europepmc +1 more source

